Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Enanta Pharmaceuticals (NASDAQ: ENTA)
Follow
NASDAQ:ENTA
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
ENTA
Enanta Pharmaceuticals
Kowalsky Matthew Paul
/
officer: Chief Legal Officer
04/29/2024
Buy
$13.25
150,000
$1.988M
150,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Vance Terry
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
Russell Lesley
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
Peterson Kristine
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
Hata Yujiro S
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
FOLETTA MARK G
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
CARTER BRUCE L A
/
director
03/06/2024
Buy
$15.66
15,700
$246K
15,700
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Chief Legal Officer
02/26/2024
Sell
$8.99
5,187
$47K
77,813
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Chief Legal Officer
02/26/2024
Buy
$8.99
5,187
$47K
75,688
NASDAQ
ENTA
Enanta Pharmaceuticals
Luu Brendan
/
officer: Chief Business Officer
02/12/2024
Sell
$12.41
973
$12K
39,083
NASDAQ
ENTA
Enanta Pharmaceuticals
Kieffer Tara Lynn
/
officer: Chief Product Strategy Officer
02/12/2024
Sell
$12.41
973
$12K
39,607
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Chief Legal Officer
02/12/2024
Sell
$12.41
973
$12K
70,501
NASDAQ
ENTA
Enanta Pharmaceuticals
Rottinghaus Scott T.
/
officer: Chief Medical Officer
02/12/2024
Sell
$12.41
755
$9K
28,287
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Chief Scientific Officer
02/12/2024
Sell
$12.41
1,080
$13K
373,295
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Chief Fin. & Admin Officer
02/12/2024
Sell
$12.41
973
$12K
95,896
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
02/12/2024
Sell
$12.41
1,584
$20K
810,609
NASDAQ
ENTA
Enanta Pharmaceuticals
Vance Terry
/
director
12/13/2023
Sell
$9.12
15,295
$139K
5,800
NASDAQ
ENTA
Enanta Pharmaceuticals
Luu Brendan
/
officer: Sr. VP, Business Dev.
12/05/2023
Sell
$9.63
2,125
$20K
36,736
NASDAQ
ENTA
Enanta Pharmaceuticals
Kieffer Tara Lynn
/
officer: Sr. VP, New Prod. Strat. & Dev
12/05/2023
Sell
$9.63
2,125
$20K
37,260
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
12/05/2023
Sell
$9.63
2,412
$23K
68,154
NASDAQ
ENTA
Enanta Pharmaceuticals
Rottinghaus Scott T.
/
officer: Sr. VP & CMO
12/05/2023
Sell
$9.63
534
$5K
26,466
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP, R&D & CSO
12/05/2023
Sell
$9.63
2,412
$23K
370,695
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Sr. VP, Finance & Admin. & CFO
12/05/2023
Sell
$9.63
2,412
$23K
93,549
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
12/05/2023
Sell
$9.63
7,230
$70K
806,793
NASDAQ
ENTA
Enanta Pharmaceuticals
Luu Brendan
/
officer: Sr. VP, Business Dev.
12/01/2023
Sell
$9.49
753
$7K
38,861
NASDAQ
ENTA
Enanta Pharmaceuticals
Kieffer Tara Lynn
/
officer: Sr. VP, New Prod. Strat. & Dev
12/01/2023
Sell
$9.49
753
$7K
39,385
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
12/01/2023
Sell
$9.49
1,595
$15K
70,566
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP, R&D & CSO
12/01/2023
Sell
$9.49
1,595
$15K
373,107
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Sr. VP, Finance & Admin. & CFO
12/01/2023
Sell
$9.49
1,595
$15K
95,961
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
12/01/2023
Sell
$9.49
5,787
$55K
814,023
NASDAQ
ENTA
Enanta Pharmaceuticals
Luu Brendan
/
officer: Sr. VP, Business Dev.
11/22/2023
Buy
$8.99
83,000
$746K
83,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Kieffer Tara Lynn
/
officer: Sr. VP, New Prod. Strat. & Dev
11/22/2023
Buy
$8.99
83,000
$746K
83,000
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Sr. VP, Finance & Admin. & CFO
11/22/2023
Buy
$8.99
83,000
$746K
83,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
11/22/2023
Buy
$8.99
83,000
$746K
83,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP, R&D & CSO
11/22/2023
Buy
$8.99
86,000
$773K
86,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Rottinghaus Scott T.
/
officer: Sr. VP & CMO
11/22/2023
Buy
$8.99
86,000
$773K
86,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
11/22/2023
Buy
$8.99
264,000
$2.373M
264,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
04/18/2023
Buy
$30.00
6,667
$200K
79,980
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
04/18/2023
Sell
$30.00
6,667
$200K
7,000
NASDAQ
ENTA
Enanta Pharmaceuticals
Vance Terry
/
director
03/16/2023
Buy
$14.00
5,800
$81K
21,095
NASDAQ
ENTA
Enanta Pharmaceuticals
Vance Terry
/
director
03/16/2023
Sell
$14.00
5,800
$81K
0
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
03/15/2023
Buy
$14.00
10,440
$146K
107,996
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
03/15/2023
Sell
$43.96
100
$4K
107,896
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
03/15/2023
Sell
$44.43
10,340
$459K
97,556
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
03/15/2023
Sell
$14.00
10,440
$146K
0
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP & CSO
03/15/2023
Buy
$14.00
13,925
$195K
388,627
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP & CSO
03/15/2023
Sell
$43.92
269
$12K
388,358
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP & CSO
03/15/2023
Sell
$44.46
13,656
$607K
374,702
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP & CSO
03/15/2023
Sell
$14.00
13,925
$195K
0
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
03/13/2023
Buy
$14.00
27,912
$391K
847,722
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
03/13/2023
Sell
$44.81
10,697
$479K
837,025
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
03/13/2023
Sell
$45.31
15,649
$709K
821,376
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
03/13/2023
Sell
$46.13
1,566
$72K
819,810
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
03/13/2023
Sell
$14.00
27,912
$391K
0
NASDAQ
ENTA
Enanta Pharmaceuticals
Vance Terry
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
Russell Lesley
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
Peterson Kristine
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
Hata Yujiro S
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
FOLETTA MARK G
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
CARTER BRUCE L A
/
director
03/02/2023
Buy
$47.72
10,800
$515K
10,800
NASDAQ
ENTA
Enanta Pharmaceuticals
Luu Brendan
/
officer: Sr. VP, Business Dev.
02/13/2023
Sell
$52.77
6,416
$339K
39,614
NASDAQ
ENTA
Enanta Pharmaceuticals
Kieffer Tara Lynn
/
officer: Sr. VP, New Product Dev.
02/13/2023
Sell
$52.77
6,725
$355K
40,138
NASDAQ
ENTA
Enanta Pharmaceuticals
Gardiner Nathaniel S.
/
officer: Sr. VP & General Counsel
02/13/2023
Sell
$52.77
6,735
$355K
73,313
NASDAQ
ENTA
Enanta Pharmaceuticals
Or Yat Sun
/
officer: Sr. VP & CSO
02/13/2023
Sell
$52.77
7,752
$409K
374,702
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
02/13/2023
Sell
$52.77
6,904
$364K
97,556
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
02/13/2023
Sell
$52.77
20,591
$1.087M
819,810
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
director, officer: President and CEO
02/13/2023
Sell
$52.77
20,591
$1.087M
799,219
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
02/09/2023
Sell
$53.64
4,200
$225K
84,263
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
02/09/2023
Sell
$54.41
800
$44K
83,463
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
01/09/2023
Buy
$14.18
2,812
$40K
88,463
NASDAQ
ENTA
Enanta Pharmaceuticals
MELLETT PAUL J
/
officer: Treasurer and CFO
12/19/2022
Buy
$14.18
4,148
$59K
85,651
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
officer: President and CEO
12/19/2022
Buy
$27.58
14,500
$400K
788,305
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
officer: President and CEO
12/16/2022
Buy
$14.00
13,851
$194K
803,805
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
officer: President and CEO
12/16/2022
Sell
$43.59
7,800
$340K
796,005
NASDAQ
ENTA
Enanta Pharmaceuticals
Luly Jay R.
/
officer: President and CEO
12/16/2022
Buy
$14.18
16,149
$229K
789,954
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.